Global Influenza Diagnostics Research Methodology Report: Incredible Possibilities, Growth With Industry Study, Detailed Analysis

Influenza is an extremely serious viral infection that affects not only the upper respiratory system but also can affect the throat, mouth, and eyes. Influenza can spread rapidly before the patient displays any symptoms, and up to approximately 7 days afterward. The global influenza diagnostics market is expected to grow at a high rate due to growing prevalence of influenza worldwide.

Drivers:

Increasing prevalence of influenza, growing research funding for influenza diagnosis, and rising demand for control and early diagnosis of influenza are the major factors driving growth of the global influenza diagnostics market. For instance, as per the World Health Organization (WHO) report, the seasonal influenza results in about three to five million cases of serious illness worldwide.

For PFD Copy of This Research Report + All Related Graphs & Charts: https://www.worldwidemarketreports.com/sample/347034
Restraints:

Rising healthcare costs due to which novel influenza diagnostics techniques are limited is the major factor restraining growth of the global influenza diagnostics market.

Regional Analysis:

North America dominates the global influenza diagnostics market due to high prevalence of influenza and growing number of influenza tests performed in the region. For instance, as per the United States Centers for Disease Control and Prevention, during the flu season of 2019-2020 more than 18 million people in the United States became sick with the flu among which 410,000 were hospitalized and about 24,000 deaths were reported.

Competitive Section:

Key players of the global influenza diagnostics market are Quidel Corporation, F. Hoffman-La Roche AG, Abbott Laboratories, Thermo Fisher Scientific, Hologic, Dickinson, Becton, Luminex Corporation, GenMark Diagnostics, Meridian Bioscience, Sekisui Diagnostics, SA Scientific Diagnostics, Danaher Corporation, bioMerieux SA, Siemens Healthineers, ELITech, Tecan Trading AG, Coris BioCOncept, Altona Diagnostics, and Genome Diagnostics.

In March 2018, Sekisui Diagnostics with Mesa Biotech launched their Silaris Influenza A and B test.

In 2018, Quidel Corporation’s QuickVue Influenza A+B Test product received its approval.

Contact Us:

Mr. Shah
Worldwide Market Reports
Seattle, WA 98154,
U.S.
Email: sales@worldwidemarketreports.com

Worldwide Market Reports provides customized upon request. This report can be personalized to suit your needs. Please contact the research team to ensure you receive the report that fits your needs.

This release was published on openPR.